ArticleCancers2024

Risk of Esophageal and Gastric Cancer in Patients with Type 2 Diabetes Receiving Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A National Analysis.

Mark Ayoub et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.